Shasun Chemicals has licensed its Buchwald cross-coupling technology to Merck & Co for API manufacture. Shasun will receive upfront payments from Merck and expects contractual rights from Merck if products are commercialised.
Hindu Business Line
Wednesday 27 February 2008
Shasun signs Merck deal
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment